Provenance trace
Audit trail · sunitinib → STAT3 → prurigo nodularis
4 source papers, 4 extracted claims, scored by Swanson ABC chain.
Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.
1Source papers4
2Extracted claims4
Each row is one structured triple extracted by deepseek-v4-flash (prompt v1_2026_05_07,
source: configured). Confidence is the LLM's self-rating.
- sunitinibinhibitsSTAT3A→B
- STAT3associated_withprurigo nodularisB→C
- STAT3associated_withprurigo nodularisB→C
- STAT3associated_withprurigo nodularisB→C
No claims match this filter.
3Bridging logicSwanson ABC
- edge_support_log_ab
- log(ab + 1) =
0.693 - edge_support_log_bc
- log(bc + 1) =
1.386 - novelty_factor
1.000(no direct drug→outcome evidence — full novelty)- direct_a_to_c_count
0
4Embedding modelbge-m3
Embeddings are used at the L1 filtering stage to prune off-topic abstracts before claim extraction. They do not directly score the hypothesis.
- model
bge-m3- dim
1024- max_length
8192tokens- similarity_scores
- No per-hypothesis cosine scores stored.
5Final scoringhigh · 0.312
- method
swanson_abc_log_evidence_with_novelty_penalty- formula
score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)- raw score
0.2079- outreach score
0.3119- quality tier
high
Horizontal exploration
Similar hypotheses
Closest 8 of 1,618 hypotheses, ranked by hybrid score (50% bge-m3 embedding cosine · 40% drug/mediator/outcome overlap · 10% shared evidence papers).
- Alternative drug0.83niclosamide→STAT3→prurigo nodularis
Different drug, same disease outcome
- Alternative drug0.83LLL12b→STAT3→prurigo nodularis
Different drug, same disease outcome
- Alternative drug0.82D11→STAT3→prurigo nodularis
Different drug, same disease outcome
- Alternative drug0.82MEK inhibitors→STAT3→prurigo nodularis
Different drug, same disease outcome
- Alternative drug0.82Stattic→STAT3→prurigo nodularis
Different drug, same disease outcome
How this hypothesis evolved
First captured May 12, 2026, latest May 13, 2026. 2 snapshots.